2019
DOI: 10.1007/s40556-019-00196-9
|View full text |Cite
|
Sign up to set email alerts
|

Outcome of Pregnancies with Isolated Absent Fetal Nasal Bone in the Second Trimester

Abstract: Absent nasal bone is associated with 58 genetic syndromes, Trisomy 18 and trisomy 21. It increases the sensitivity of second trimester scan for aneuploidy from 83 to 90%. Since 2003, absent or unossified nasal bone is therefore an integral part of the second trimester scan. The present study aimed at confirming the sensitivity of isolated absent NB in the second trimester USG, by reviewing the karyotypes and/or postnatal outcomes of such pregnancies up till at least 6 months of postnatal life. Facial profile w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
(5 reference statements)
0
1
0
Order By: Relevance
“…Consequently, it is far more practical to perform a thorough scan at around 16 weeks to look for soft signs other than AHNB, and then to prioritize the woman for intrusive testing. Numerous studies have proposed a similar methodology (Benacerraf et al, 2019; Desai et al, 2019; Zhang et al, 2021) Adhering to this strategy in low‐resource situations will lower costs and the number of invasive treatments performed. However, when doing invasive testing, the sample should be sent for a more detailed analysis of the genomic structure of the fetus, like the microarray, over the conventional karyotype, as has been outlined in several studies (Fantasia et al, 2020; Gu et al, 2019; Shi et al, 2022; Zhang et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Consequently, it is far more practical to perform a thorough scan at around 16 weeks to look for soft signs other than AHNB, and then to prioritize the woman for intrusive testing. Numerous studies have proposed a similar methodology (Benacerraf et al, 2019; Desai et al, 2019; Zhang et al, 2021) Adhering to this strategy in low‐resource situations will lower costs and the number of invasive treatments performed. However, when doing invasive testing, the sample should be sent for a more detailed analysis of the genomic structure of the fetus, like the microarray, over the conventional karyotype, as has been outlined in several studies (Fantasia et al, 2020; Gu et al, 2019; Shi et al, 2022; Zhang et al, 2021).…”
Section: Discussionmentioning
confidence: 99%